Diabetologists to get specialised trainingThe European Association for the Study of Diabetes (EASD), the Gulf Group for the Study of Diabetes (GGSD) and US-based Lilly signed an agreement towards providing post graduate continued education for diabetologists across the GCC. Under More… |
Lilly drug boosts good cholesterolAn experimental heart drug from Eli Lilly and Co dramatically boosted levels of "good" cholesterol and appeared to be safe, according to data from a clinical trial. The report provides new hope for a class of medicines with a troubled past More… |
Amylin, Lilly end diabetes partnershipAmylin Pharmaceuticals will pay Eli Lilly and Company $250 million up front and as much as $1.2 billion in the future for rights to their diabetes products, ending what was once one of the drug industry's most successful partnerships. The More… |
Judge blocked generic Evista launch, says LillyEli Lilly and Co has said that a federal judge issued a preliminary injunction preventing the launch of a generic version of osteoporosis drug Evista. Lilly said the action by Judge Sarah Barker of US District Court, Southern District of I More… |
Drive to create diabetes awareness through artThe ‘Inspired by Diabetes’ campaign, a collaboration between Lilly and the International Diabetes Federation’s (IDF) Unite for Diabetes initiative, has been launched in Egypt. The campaign, which has received endorsement from the National More… |